Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
The cestode E. multilocularis causes the disease alveolar echinococcosis (AE) in humans. The continuously proliferating metacestode (larval stage) of the parasite infects mostly the liver and exhibits tumor-like growth. Current chemotherapeutical treatment options rely on benzimidazoles, which are r...
Main Authors: | Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva, Adriele da Silva Araujo, Deborah Elisabeth Joekel, David Czock, Christine Goepfert, Adriana Marques Moraes, Marcus Vinicius Nora de Souza, Joachim Müller, Meike Mevissen, Andrew Hemphill, Britta Lundström-Stadelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320718300617 |
Similar Items
-
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
by: Britta Lundström-Stadelmann, et al.
Published: (2020-08-01) -
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis
by: Reto Rufener, et al.
Published: (2018-12-01) -
Author Correction: In vitro metabolomic footprint of the Echinococcus multilocularis metacestode
by: Dominic Ritler, et al.
Published: (2021-02-01) -
Clinical pharmacology of mefloquine
by: Karbwang, J.
Published: (1987) -
Mefloquine in the treatment of cutaneous leishmaniasis
by: Correia Dalmo, et al.
Published: (1999-01-01)